Ftse Mib
34.180,17
0,57%
DAX
18.396,60
1,24%
S&P 500
5.191,53
0,21%
NASDAQ
16.338,20
-0,07%
Bitcoin
63.476,74
0,49%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Calliditas Therapeutics AB (CALT) Calliditas Therapeutics AB (CALT) Notizie

Calliditas Therapeutics AB

CALT
20,13
0,00 (0,00%)
Ultimo aggiornamento: 16:36:08
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Ricevuta di Deposito
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
06/5/202408:16PRNUSCalliditas announces positive topline results of Phase 2..
06/5/202408:11PRNUSCalliditas announces positive topline results of Phase 2..
24/4/202419:35PRNUSCalliditas Therapeutics' 2023 Annual Report Published
24/4/202419:26PRNUSCalliditas Therapeutics' 2023 Annual Report Published
24/4/202409:30PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
24/4/202409:26PRNUSCalliditas Announces Positive NefIgArd Open Label Extension..
18/4/202413:13PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
18/4/202413:10PRNUSCalliditas Therapeutics Presents Additional Data Analyses..
09/4/202413:24PRNUSCalliditas Therapeutics to Attend Conferences in April
09/4/202413:22PRNUSCalliditas Therapeutics to Attend Conferences in April
08/4/202414:38PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
08/4/202414:32PRNUSCalliditas Therapeutics to Present Nefecon Data at the ISN..
08/4/202409:24PRNUSCalliditas receives notice of allowance for United States..
08/4/202409:22PRNUSCalliditas receives notice of allowance for United States..
12/3/202402:28PRNUSEverest Medicines' Partner Calliditas Therapeutics Announces..
06/3/202408:38PRNUSCalliditas announces an additional seven year orphan drug..
06/3/202408:34PRNUSCalliditas announces an additional seven year orphan drug..
01/3/202413:43PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
01/3/202413:39PRNUSCalliditas Therapeutics to Attend Investor Conferences in..
21/2/202407:45PRNUSCalliditas Year-end report, January - December 2023
21/2/202407:43PRNUSCalliditas Year-end report, January - December 2023
14/2/202407:11PRNUSInvitation to the presentation of Calliditas´ Year-end..
14/2/202407:09PRNUSInvitation to the presentation of Calliditas´ Year-end..
13/2/202417:28PRNUSCalliditas provides patent update
13/2/202417:26PRNUSCalliditas provides patent update
08/1/202414:28EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
08/1/202408:33PRNUSCalliditas Therapeutics provides business update ahead of JP..
08/1/202408:31PRNUSCalliditas Therapeutics provides business update ahead of JP..
07/1/202417:21PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
07/1/202417:19PRNUSCalliditas Therapeutics appoints Maria Törnsén as President..
07/1/202417:07PRNUSCalliditas to present at JP Morgan Healthcare Conference
07/1/202417:05PRNUSCalliditas to present at JP Morgan Healthcare Conference
27/12/202322:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
27/12/202318:22PRNUSCalliditas refinances existing term loan with Euro 92..
27/12/202318:16PRNUSCalliditas refinances existing term loan with Euro 92..
21/12/202301:00DJNStocks to Watch: Micron, Warner Bros. Discovery, Paramount..
20/12/202323:33DJNCalliditas Therapeutics Shares Rise 33% After FDA Approves..
20/12/202323:13EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
20/12/202322:34PRNUSCalliditas Therapeutics announces full FDA approval of..
20/12/202322:33PRNUSCalliditas Therapeutics announces full FDA approval of..
11/12/202315:40PRNUSCalliditas Receives Notice of Allowance for United States..
11/12/202315:38PRNUSCalliditas Receives Notice of Allowance for United States..
01/12/202309:27PRNUSCalliditas announces additions to the management team
01/12/202309:21PRNUSCalliditas announces additions to the management team
30/11/202308:55PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
30/11/202308:49PRNUSCalliditas initiates clinical study to evaluate setanaxib in..
24/11/202309:13PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
24/11/202309:10PRNUSCalliditas' partner Everest Medicines announces China NMPA's..
07/11/202316:31PRNUSCalliditas to present at upcoming investor conferences
07/11/202316:29PRNUSCalliditas to present at upcoming investor conferences
Apertura: 20,13 Min: 20,13 Max: 20,13
Chiusura: 20,13

La tua Cronologia

NASDAQ
CALT
Calliditas Therapeutics AB
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network